These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 23981463

  • 1. Appropriate clinical use of statins: a discussion of the evidence, scope, benefits, and risk.
    Perlmutter D, Golomb B, Sinatra S, Campbell AW.
    Altern Ther Health Med; 2013; 19 Suppl 1():14-25. PubMed ID: 23981463
    [No Abstract] [Full Text] [Related]

  • 2. Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.
    Nicholls SJ, Uno K, Kataoka Y.
    Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1383-90. PubMed ID: 22059787
    [Abstract] [Full Text] [Related]

  • 3. Should every patient with diabetes receive a statin?
    Dembowski E, Davidson MH.
    Pol Arch Med Wewn; 2008 Nov; 118(7-8):398-401. PubMed ID: 18714733
    [No Abstract] [Full Text] [Related]

  • 4. Lipid lowering for primary prevention.
    Yusuf S, Lonn E, Bosch J.
    Lancet; 2009 Apr 04; 373(9670):1152-5. PubMed ID: 19345816
    [No Abstract] [Full Text] [Related]

  • 5. Beyond statins: what to expect from add-on lipid regulating therapy?
    Laufs U, Weintraub WS, Packard CJ.
    Eur Heart J; 2013 Sep 04; 34(34):2660-5. PubMed ID: 23832488
    [No Abstract] [Full Text] [Related]

  • 6. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
    Lavie G, Cohen S.
    Harefuah; 2015 Jun 04; 154(6):382-6, 404. PubMed ID: 26281083
    [Abstract] [Full Text] [Related]

  • 7. [Treatment with statins: lowering of cholesterol or more?].
    Rutishauser J.
    Praxis (Bern 1994); 2006 Jan 25; 95(4):107-10. PubMed ID: 16485605
    [No Abstract] [Full Text] [Related]

  • 8. Some question use of statins to reduce cardiovascular risks in healthy women.
    Mitka M.
    JAMA; 2012 Mar 07; 307(9):893-4. PubMed ID: 22396503
    [No Abstract] [Full Text] [Related]

  • 9. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
    Chodick G, Shalev V.
    Arch Intern Med; 2010 Dec 13; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
    [No Abstract] [Full Text] [Related]

  • 10. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G, Maggioni AP.
    Adv Ther; 2009 May 13; 26(5):469-87. PubMed ID: 19444394
    [Abstract] [Full Text] [Related]

  • 11. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I, Krone W.
    Dtsch Med Wochenschr; 2006 Dec 13; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [Abstract] [Full Text] [Related]

  • 12. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.
    Clearfield MB.
    J Am Osteopath Assoc; 2010 Apr 13; 110(4 Suppl 4):S2-6. PubMed ID: 20453192
    [Abstract] [Full Text] [Related]

  • 13. Update on statins and other lipid-lowering drugs.
    Miller CA.
    Geriatr Nurs; 2001 Apr 13; 22(5):276-7. PubMed ID: 11606910
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks.
    Minder CM, Blumenthal RS, Blaha MJ.
    Curr Opin Cardiol; 2013 Sep 13; 28(5):554-60. PubMed ID: 23928920
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Addressing cardiovascular risk beyond low-density lipoprotein cholesterol: the high-density lipoprotein cholesterol story.
    Meagher EA.
    Curr Cardiol Rep; 2004 Nov 13; 6(6):457-63. PubMed ID: 15485608
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.